Cargando…

Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson’s Disease

Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the Substantia Nigra pars compacta, leading to classical PD motor symptoms. Current therapies are purely symptomatic and do not modify disease progression. Cannabidiol (CBD), one of the main...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giuliano, Claudio, Francavilla, Miriam, Ongari, Gerardo, Petese, Alessandro, Ghezzi, Cristina, Rossini, Nora, Blandini, Fabio, Cerri, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396349/ https://www.ncbi.nlm.nih.gov/pubmed/34445626 http://dx.doi.org/10.3390/ijms22168920

Ejemplares similares

Profiling the Biochemical Signature of GBA‐Related Parkinson's Disease in Peripheral Blood Mononuclear Cells
por: Avenali, Micol, et al.
Publicado: (2021)

Potential therapeutic effects of polyphenols in Parkinson’s disease: in vivo and in vitro pre-clinical studies
por: Giuliano, Claudio, et al.
Publicado: (2020)

GBA Mutations Influence the Release and Pathological Effects of Small Extracellular Vesicles from Fibroblasts of Patients with Parkinson’s Disease
por: Cerri, Silvia, et al.
Publicado: (2021)

Peripheral-Central Neuroimmune Crosstalk in Parkinson's Disease: What Do Patients and Animal Models Tell Us?
por: Fuzzati-Armentero, Marie Therese, et al.
Publicado: (2019)

Parkinson’s Disease in Women and Men: What’s the Difference?
por: Cerri, Silvia, et al.
Publicado: (2019)

Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease
por: Avenali, Micol, et al.
Publicado: (2020)

Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease
por: Milanese, Chiara, et al.
Publicado: (2020)

Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease
por: Patricio, Felipe, et al.
Publicado: (2020)

Cannabidiol in Parkinson’s disease
por: Rieder, Carlos R.
Publicado: (2020)

Channelopathy of Dravet Syndrome and Potential Neuroprotective Effects of Cannabidiol
por: Xu, Changqing, et al.
Publicado: (2021)

Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation
por: Galvagnion, Céline, et al.
Publicado: (2022)

Hemp in Animal Diets—Cannabidiol
por: Fallahi, Sepideh, et al.
Publicado: (2022)

Formulation of Nanomicelles Loaded with Cannabidiol as a Platform for Neuroprotective Therapy
por: Yordanov, Yordan, et al.
Publicado: (2022)

Neuroprotection of cannabidiol in epileptic rats: Gut microbiome and metabolome sequencing
por: Gong, Xiaoxiang, et al.
Publicado: (2022)

Cannabidiol's neuroprotective properties and potential treatment of traumatic brain injuries
por: Aychman, Mackenzie M., et al.
Publicado: (2023)

Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease
por: Esposito, Emanuela, et al.
Publicado: (2012)

Neuroprotective Transcription Factors in Animal Models of Parkinson Disease
por: Blaudin de Thé, François-Xavier, et al.
Publicado: (2016)

Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
por: Martinez, Bridget, et al.
Publicado: (2018)

Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents
por: Dias Viegas, Flávia P., et al.
Publicado: (2022)

The Exosomal/Total α-Synuclein Ratio in Plasma Is Associated With Glucocerebrosidase Activity and Correlates With Measures of Disease Severity in PD Patients
por: Cerri, Silvia, et al.
Publicado: (2018)

Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
por: Campos, Alline C., et al.
Publicado: (2017)

Neuroprotective Effect of Cannabidiol Against Hydrogen Peroxide in Hippocampal Neuron Culture
por: Kim, Jungnam, et al.
Publicado: (2021)

Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease
por: Milanese, Chiara, et al.
Publicado: (2018)

Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson’s Disease
por: Burgaz, Sonia, et al.
Publicado: (2021)

Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease
por: Siani, Francesca, et al.
Publicado: (2017)

A(2A) Receptor Antagonism and Dyskinesia in Parkinson's Disease
por: Morelli, Micaela, et al.
Publicado: (2012)

Cannabidiol Exerts a Neuroprotective and Glia-Balancing Effect in the Subacute Phase of Stroke
por: Meyer, Erika, et al.
Publicado: (2022)

Neuroprotective and Neuromodulatory Effects Induced by Cannabidiol and Cannabigerol in Rat Hypo-E22 cells and Isolated Hypothalamus
por: di Giacomo, Viviana, et al.
Publicado: (2020)

The natural Disc1-deletion present in several inbred mouse strains does not affect sleep
por: Dittrich, Lars, et al.
Publicado: (2017)

Antioxidant and Neuroprotective Effects Induced by Cannabidiol and Cannabigerol in Rat CTX-TNA2 Astrocytes and Isolated Cortexes
por: di Giacomo, Viviana, et al.
Publicado: (2020)

Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine
por: Greco, Rosaria, et al.
Publicado: (2023)

Action and emotion perception in Parkinson’s disease: A neuroimaging meta-analysis
por: Arioli, Maria, et al.
Publicado: (2022)

Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease
por: Palasz, Ewelina, et al.
Publicado: (2019)

Neuroprotective potential of Cordia dichotoma in Parkinson's syndrome induced by haloperidol: An animal study
por: Bhavani, Keserla, et al.
Publicado: (2023)

Biological bases for a possible effect of cannabidiol in Parkinson’s disease
por: Ferreira-Junior, Nilson C., et al.
Publicado: (2019)

Cannabidiol and Tetrahydrocannabinol Use in Parkinson’s Disease: An Observational Pilot Study
por: Sousa, Amber, et al.
Publicado: (2023)

Correction: Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine
por: Greco, Rosaria, et al.
Publicado: (2023)

Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation
por: El-Remessy, A.B., et al.
Publicado: (2008)

Advances in Neuroprotective Ingredients of Medicinal Herbs by Using Cellular and Animal Models of Parkinson's Disease
por: More, Sandeep Vasant, et al.
Publicado: (2013)

Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease
por: Wąsik, Agnieszka, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ptaasld1mn67f498f4eikmg0e7